BioSpace News Archive

Feb. 25, 2020 14:01 UTC ClinOne’s CEO offers its suite of technologies at no cost to support any sponsor conducting clinical vaccine trials for the COVID-19 coronavirus. DENVER--( BUSINESS WIRE )-- In December 2019, cases of Influenza, primarily Influenza A and Influenza B, were climbing dramatically within the United States. Globally, Influenza A was in full force, with symptoms including cough, fever, chills, sore throat, nasal congestion, headache, and fatigue. At that v

Feb. 25, 2020 14:17 UTC Studies planned to compare sugarBEAT® and major continuous glucose monitor sensor, seeking to position sugarBEAT® as both a possible alternative and complementary device for people with diabetes LOUGHBOROUGH, England--( BUSINESS WIRE )-- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT® its non

The new, minimally invasive approach to fistulas has changed the way doctors prepare their patients for hemodialysis.

NEW YORK , Feb. 25, 2020 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced its attendance at the AI & ML Drug Discovery Summit . The AI-ML in Drug Development Summit is the only conference to bring together industry leaders, technology experts and academics focused on augmenting the R&D processes through the use of Artificial Intelligence and Machine

Feb. 25, 2020 14:59 UTC NEW YORK--( BUSINESS WIRE )-- Enzo Biochem (NYSE:ENZ) announced preliminary results of voting at the 2019 Annual Shareholder meeting held today. According to these preliminary results, shareholders did not approve the proposal to increase the size of Board, voted to elect Fabian Blank, Peter Clemens and Rebecca Fischer to the Board of Directors, approved the non-binding advisory resolution on executive compensation, ratified the appointment of Enzo’s ind

Healthcare agency to build thought leadership for population health management solutions provider [25-February-2020] SCOTTSDALE, Ariz. , Feb. 25, 2020 /PRNewswire/ -- Amendola Communications, a nationally recognized, award-winning healthcare and technology public relations and marketing firm, announced today that CareMount Medical has engaged the agency to provide str

The following is attributed to Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health [25-February-2020] SILVER SPRING, Md. , Feb. 25, 2020 /PRNewswire/ -- Today, we are taking several important steps to make the use of laparoscopic power morcellators (LPMs) safer in gynecologic surgeries, including granting marketing authorization f

Stryker announced that Lisa Skeete Tatum has been nominated for election to the company’s Board of Directors at Stryker’s 2020 Annual Meeting of Shareholders, which will be held on May 5, 2020.

Tarveda Therapeutics, Inc., a clinical stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin® miniature drug conjugates, today announced that Drew Fromkin, President and Chief Executive Officer, will present at the Cowen & Company 40th Annual Health Care Conference,

PhysIQ and the U.S. VA publish results of a clinical trial that demonstrates how artificial intelligence (AI) applied to continuous wearable sensor data may predict hospitalizations.